We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

151 hedge funds and large institutions have $916M invested in Exact Sciences in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 12

64% more call options, than puts

Call options by funds: $67.8M | Put options by funds: $41.3M

22% more capital invested

Capital invested by funds: $752M → $916M (+$164M)

15% more funds holding

Funds holding: 131151 (+20)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 51

Holders
151
Holders Change
+20
Holders Change %
+15.27%
% of All Funds
4.36%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
32
Increased
49
Reduced
51
Closed
12
Calls
$67.8M
Puts
$41.3M
Net Calls
+$26.5M
Net Calls Change
+$31.6M
Name Holding Trade Value Shares
Change
Change in
Stake
PAI
26
Palo Alto Investors
California
$11M -$109K -8,100 -1%
Fidelity International
27
Fidelity International
Bermuda
$10.3M +$9.85M +729,367 New
Mackenzie Financial
28
Mackenzie Financial
Ontario, Canada
$10M -$1.14M -84,100 -11%
Schroder Investment Management Group
29
Schroder Investment Management Group
United Kingdom
$9.45M +$9.01M +667,000 New
Capital World Investors
30
Capital World Investors
California
$7.23M
TA
31
Teton Advisors
New York
$6.47M +$1.72M +127,040 +39%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$5.64M -$160K -11,849 -3%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$5.53M +$178K +13,166 +3%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$5.19M -$70.2K -5,200 -1%
B
35
Baird
Wisconsin
$5.19M +$2.06M +152,260 +71%
UBS AM
36
UBS AM
Illinois
$5M -$708K -52,400 -13%
SC
37
Skylands Capital
Wisconsin
$4.94M +$635K +47,050 +16%
TIM
38
Thompson Investment Management
Wisconsin
$4.88M -$84.1K -6,230 -2%
SI
39
Stephens Inc
Arkansas
$4.82M +$4.59M +340,247 New
Principal Financial Group
40
Principal Financial Group
Iowa
$4.49M -$59.2K -4,384 -1%
TAM
41
Timucuan Asset Management
Florida
$4.36M
TCIM
42
TIAA CREF Investment Management
New York
$3.9M -$79.8K -5,910 -2%
RP
43
Reinhart Partners
Wisconsin
$3.75M -$2.8M -207,340 -44%
CCM
44
Cupps Capital Management
Illinois
$3.37M +$3.21M +238,029 New
MHP
45
Manatuck Hill Partners
Connecticut
$3.23M -$2.89M -214,300 -48%
GC
46
Guggenheim Capital
Illinois
$3.22M -$76.8K -5,690 -2%
HighTower Advisors
47
HighTower Advisors
Illinois
$3.22M -$352K -26,049 -10%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$3.1M +$136K +10,081 +4%
DIA
49
Denver Investment Advisors
Colorado
$2.97M -$766K -56,719 -21%
Canada Life
50
Canada Life
Manitoba, Canada
$2.88M -$246K -18,194 -8%

EXAS Hedge Fund Activity: Q1 2014 in Review

151 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2014, worth a combined $916M — up 22% from $752M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new EXAS positions and 12 closed out — a net gain of 20 holders — while 49 added to existing stakes and 51 trimmed.

The largest buyer was Invesco, adding an estimated $26.7M. The largest seller was OrbiMed, cutting an estimated $41.8M.

  • 151 institutional investors held Exact Sciences (EXAS) as of Q1 2014, up from 131 in Q4 2013.
  • Funds reported $916M of Exact Sciences stock for Q1 2014, up 22% quarter-over-quarter.
  • 32 funds opened new Exact Sciences positions in Q1 2014 and 12 closed out, a net change of +20 holders.
  • The largest Exact Sciences buyer in Q1 2014 was Invesco, an estimated $26.7M added.
  • The largest Exact Sciences seller in Q1 2014 was OrbiMed, an estimated $41.8M sold.

Based on aggregated 13F filings for Q1 2014.